I figured I had better get rid of some e-mails and noticed I never
responded to your question.
Once the sponsor requirements are met and all costs associated with
the delivery of those requirements have been charged, then I close
the account out to the PI's research account in fund 23. The entire
balance or the residuals are at the discretion of the PI.
>>> xxxxxx@CMH.EDU 07/11/00 02:44PM >>>
When funds remain after all bills are paid for industry-sponsored
projects,
half the funds go to an account used to support the research of
the
investigator(s). The other half goes to an unrestricted account in
the
investigator's home section/department which is most often used to
support
additional research. The investigator is free to support any
research s/he
desires as long as it is within the mission of the hospital and
meets all
other requirements. We consider all industry-sponsored contracts
fixed-price
contracts, unless the terms and conditions state otherwise, and
that any
residual is not connected to the original project. We close out the
project
account upon tranfer of any residual funds.
Bill Caskey, PhD
Director, Research & Grants Administration
Children's Mercy Hospital
2401 Gillham Road
Kansas City, MO 64108
Voice:(816) 234-3879
FAX:(816) 855-1982
E-mail: xxxxxx@cmh.edu <mailto:xxxxxx@cmh.edu>
This communication is intended only for the use of the addressee.
It
may contain information which is privileged or confidential under
applicable law. If you are not the intended recipient or the agent
of
the recipient, you are hereby notified that any dissemination, copy
or
disclosure of this communication is strictly prohibited. If you
have
received this communication in error, please immediately notify
The
Children's Mercy Hospital at 816-234-3879 or via return Internet
electronic mail at xxxxxx@cmh.edu <mailto:xxxxxx@cmh.edu> and
expunge
this communication without making any copies. Thank you for your
cooperation.
-----Original Message-----
From: Doug Wilkerson [mailto:xxxxxx@MCO.EDU]
Sent: Monday, July 10, 2000 2:46 PM
To: xxxxxx@HRINET.ORG
Subject: How Do You Handle Residual Funds?
I would be interested in knowing how those of you involved in the
management
of industry-sponsored clinical trials handle any funds remaining
AFTER all
of the work is completed, i.e., after the company has accepted all
deliverables required in the contract, and all of the bills are
paid. Do
you leave the residual funds in the same account that was
established to
support the work of the clinical trial, or move them to another
account? Do
you place restrictions on the use of the residual funds? At the
end of the
trial, do you consider any residual funds to be completely
dissociated from
the original contract and thus available for expenditure for any
research-related activity, assuming that no contract clauses
survive the
contract which might obviate this option? What if your
investigator wanted
to utilize residual funds to finance a collaborative research
agreement with
another entity for basic research, would you be comfortable with
it?
Doug Wilkerson, Ph.D. Phone: (419) 383-4252
Assoc. V.P. For Research Fax: (419) 383-4252
Professor of Pharmacology E-mail: xxxxxx@mco.edu
Research & Grants Admin. Web: www.mco.edu/research
Block Health Sci. Bldg., Rm. 148
3035 Arlington Ave.
Toledo, OH 43614-5804
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are
available
via our web site at http://www.hrinet.org (click on "Listserv
Lists")
======================================================================
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are
available
via our web site at http://www.hrinet.org (click on "Listserv
Lists")
======================================================================
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
